Group B meningococcal and group B streptococcal vaccines - Roche
Latest Information Update: 04 Nov 2017
At a glance
- Originator National Research Council Canada
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Meningococcal group B infections; Streptococcal infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Meningococcal-group-B-infections in USA
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Streptococcal-infections in USA
- 26 Jun 2007 BioVeris Corporation has been acquired and merged into Roche